Comparison Between Effect of Conventional, Intensive and Light Emitting Diodes (LED) Phototherapy on Oxidative Stress Among Neonates With Unconjugated Hyperbilirubinemia
Primary Purpose
Oxidative Stress, Neonatal Hyperbilirubinemia, Phototherapy Complication
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
phototherapy
Sponsored by
About this trial
This is an interventional treatment trial for Oxidative Stress
Eligibility Criteria
Inclusion Criteria:
- Term and late-preterm neonates (≥35weeks) according to the guidelines of the American Academy of Pediatrics (2004) which stated that gestational ages of newborns were determined according to the first day of the mother's last menstrual period (by the mother's statement) and were additionally confirmed by the Ballard scoring system (Ballard et al., 1991) and antenatal ultrasonographic estimation or obstetric records if present.
- Clinical significant indirect hyperbilirubinemia requiring phototherapy in the first week of life.
- Normal blood counts and peripheral blood smears
- Normal reticulocytic count.
- Breast fed newborn.
Exclusion Criteria:
- Those in whom the total serum bilirubin (TSB) level rose by more than 5 mg/dl per day or was higher than 20 mg/dl within the first 24 hours after birth were excluded from the study.
- Infant of diabetic mothers.
- Maternal eclampsia-preeclampsia.
- Birth asphyxia
- Sepsis
- congenital anomalies.
- Direct Coombs'test positive
- Pathological causes of hyperbilirubinemia.
- Enclosed hemorrhage.
- Hemolytic type of hyperbilirubinemia due to blood group or Rh incompatibility.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Active Comparator
Active Comparator
Arm Label
conventional phototherapy
extensive phototherapy
LED phototherapy
Arm Description
neonates with unconjugated hyperbilirubinemia exposed to conventional phototherapy
neonates with unconjugated hyperbilirubinemia exposed to extensive phototherapy
neonates with unconjugated hyperbilirubinemia exposed to LED phototherapy
Outcomes
Primary Outcome Measures
Effect of types of phototherapy on change in total antioxidant capacity (TAC)
This will be determined by:
Measure TAC (mmol/L) before and after phototherapy
Compare results of TAC (mmol/L) before and after phototherapy.
Effect of types of phototherapy on change in malonaldehyde (MDA)
This will be determined by:
Measure MDA (nmol/L) before and after phototherapy
Compare results of MDA (nmol/L) before and after phototherapy.
Effect of types of phototherapy on change in nitric oxide (NO)
This will be determined by:
Measure NO (umol/L) before and after phototherapy
Compare results of NO (umol/L) before and after phototherapy.
Secondary Outcome Measures
Effect of types of phototherapy on change in serum iron (Fe)
This will be determined by:
Measure serum Fe before and after phototherapy
Compare results of serum Fe before and after phototherapy.
Effect of types of phototherapy on change in serum copper (Cu)
This will be determined by:
Measure serum Cu before and after phototherapy
Compare results of serum Cu before and after phototherapy.
Effect of types of phototherapy on change in serum zinc (Zn)
This will be determined by:
Measure serum Zn before and after phototherapy
Compare results of serum Zn before and after phototherapy.
Effect of types of phototherapy on change in serum calcium (Zn)
This will be determined by:
Measure serum Ca before and after phototherapy
Compare results of serum Ca before and after phototherapy.
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03074292
Brief Title
Comparison Between Effect of Conventional, Intensive and Light Emitting Diodes (LED) Phototherapy on Oxidative Stress Among Neonates With Unconjugated Hyperbilirubinemia
Study Type
Interventional
2. Study Status
Record Verification Date
March 2017
Overall Recruitment Status
Unknown status
Study Start Date
December 2013 (undefined)
Primary Completion Date
March 2017 (Anticipated)
Study Completion Date
March 2017 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Rania Ali El-Farrash
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
5. Study Description
Brief Summary
The aim of the present study is to test a hypothesis assuming that phototherapy might have an effect on oxidant/antioxidant status in term and late-preterm neonates with unconjugated hyperbilirubinemia.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Oxidative Stress, Neonatal Hyperbilirubinemia, Phototherapy Complication
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
120 (Actual)
8. Arms, Groups, and Interventions
Arm Title
conventional phototherapy
Arm Type
Active Comparator
Arm Description
neonates with unconjugated hyperbilirubinemia exposed to conventional phototherapy
Arm Title
extensive phototherapy
Arm Type
Active Comparator
Arm Description
neonates with unconjugated hyperbilirubinemia exposed to extensive phototherapy
Arm Title
LED phototherapy
Arm Type
Active Comparator
Arm Description
neonates with unconjugated hyperbilirubinemia exposed to LED phototherapy
Intervention Type
Procedure
Intervention Name(s)
phototherapy
Intervention Description
estimate oxidative stress and trace elements in neonates with unconjugated hyperbilirubinemia after exposure to phototherapy
Primary Outcome Measure Information:
Title
Effect of types of phototherapy on change in total antioxidant capacity (TAC)
Description
This will be determined by:
Measure TAC (mmol/L) before and after phototherapy
Compare results of TAC (mmol/L) before and after phototherapy.
Time Frame
2 days
Title
Effect of types of phototherapy on change in malonaldehyde (MDA)
Description
This will be determined by:
Measure MDA (nmol/L) before and after phototherapy
Compare results of MDA (nmol/L) before and after phototherapy.
Time Frame
2 days
Title
Effect of types of phototherapy on change in nitric oxide (NO)
Description
This will be determined by:
Measure NO (umol/L) before and after phototherapy
Compare results of NO (umol/L) before and after phototherapy.
Time Frame
2 days
Secondary Outcome Measure Information:
Title
Effect of types of phototherapy on change in serum iron (Fe)
Description
This will be determined by:
Measure serum Fe before and after phototherapy
Compare results of serum Fe before and after phototherapy.
Time Frame
2 days
Title
Effect of types of phototherapy on change in serum copper (Cu)
Description
This will be determined by:
Measure serum Cu before and after phototherapy
Compare results of serum Cu before and after phototherapy.
Time Frame
2 days
Title
Effect of types of phototherapy on change in serum zinc (Zn)
Description
This will be determined by:
Measure serum Zn before and after phototherapy
Compare results of serum Zn before and after phototherapy.
Time Frame
2 days
Title
Effect of types of phototherapy on change in serum calcium (Zn)
Description
This will be determined by:
Measure serum Ca before and after phototherapy
Compare results of serum Ca before and after phototherapy.
Time Frame
2 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
2 Days
Maximum Age & Unit of Time
28 Days
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Term and late-preterm neonates (≥35weeks) according to the guidelines of the American Academy of Pediatrics (2004) which stated that gestational ages of newborns were determined according to the first day of the mother's last menstrual period (by the mother's statement) and were additionally confirmed by the Ballard scoring system (Ballard et al., 1991) and antenatal ultrasonographic estimation or obstetric records if present.
Clinical significant indirect hyperbilirubinemia requiring phototherapy in the first week of life.
Normal blood counts and peripheral blood smears
Normal reticulocytic count.
Breast fed newborn.
Exclusion Criteria:
Those in whom the total serum bilirubin (TSB) level rose by more than 5 mg/dl per day or was higher than 20 mg/dl within the first 24 hours after birth were excluded from the study.
Infant of diabetic mothers.
Maternal eclampsia-preeclampsia.
Birth asphyxia
Sepsis
congenital anomalies.
Direct Coombs'test positive
Pathological causes of hyperbilirubinemia.
Enclosed hemorrhage.
Hemolytic type of hyperbilirubinemia due to blood group or Rh incompatibility.
12. IPD Sharing Statement
Citations:
PubMed Identifier
30458636
Citation
El-Farrash RA, El-Shimy MS, Tawfik S, Nada AS, Salem DAD, M Gallo MS, Abd-Elmohsen EW. Effect of phototherapy on oxidant/antioxidant status: a randomized controlled trial. Free Radic Res. 2019 Feb;53(2):179-186. doi: 10.1080/10715762.2018.1549364. Epub 2019 Mar 1.
Results Reference
derived
Learn more about this trial
Comparison Between Effect of Conventional, Intensive and Light Emitting Diodes (LED) Phototherapy on Oxidative Stress Among Neonates With Unconjugated Hyperbilirubinemia
We'll reach out to this number within 24 hrs